| Title |
Is Individualized Medicine More Cost-Effective? A Systematic Review
|
|---|---|
| Published in |
PharmacoEconomics, February 2014
|
| DOI | 10.1007/s40273-014-0143-0 |
| Pubmed ID | |
| Authors |
Maximilian H. M. Hatz, Katharina Schremser, Wolf H. Rogowski |
| Abstract |
Individualized medicine (IM) is a rapidly evolving field that is associated with both visions of more effective care at lower costs and fears of highly priced, low-value interventions. It is unclear which view is supported by the current evidence. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| New Zealand | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Science communicators (journalists, bloggers, editors) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 195 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 1% |
| Colombia | 1 | <1% |
| Unknown | 192 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 30 | 15% |
| Student > Master | 29 | 15% |
| Student > Ph. D. Student | 27 | 14% |
| Student > Bachelor | 18 | 9% |
| Other | 15 | 8% |
| Other | 36 | 18% |
| Unknown | 40 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 48 | 25% |
| Economics, Econometrics and Finance | 18 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 8% |
| Psychology | 10 | 5% |
| Nursing and Health Professions | 8 | 4% |
| Other | 45 | 23% |
| Unknown | 51 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 October 2017.
All research outputs
#4,315,007
of 23,607,611 outputs
Outputs from PharmacoEconomics
#445
of 1,881 outputs
Outputs of similar age
#41,630
of 222,149 outputs
Outputs of similar age from PharmacoEconomics
#7
of 31 outputs
Altmetric has tracked 23,607,611 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,881 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 222,149 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.